WEST PHARMACEUTICAL SERVICES, INC. (WST) Operating Margin
- Operating margin · 12 months: Value 20.45%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 20.45% | Operating income / revenue. Period ending 2026-06-30. $680.40M ÷ $3.33B × 100 ≈ 20.45% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 680.40M USD | Operating Income (Loss) |
| Revenue | 3.33B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 2.10B USD | Cost of Goods and Services Sold |
| Research and development | 74.40M USD | Research and Development Expense |
| Selling, general and administration | 426.80M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $680.40M | $3.33B | $2.10B | $74.40M | $426.80M | 20.45% |
| 2026-03-31 | $655.00M | $3.22B | $2.05B | $73.80M | $405.10M | 20.34% |
| 2025-12-31 | $584.90M | $3.07B | $1.97B | $74.30M | $393.60M | 19.03% |
| 2025-09-30 | $587.90M | $3.02B | $1.94B | $71.00M | $371.90M | 19.48% |
| 2025-06-30 | $581.60M | $2.96B | $1.92B | $69.40M | $352.70M | 19.65% |
| 2025-03-31 | $554.10M | $2.90B | $1.90B | $67.80M | $339.80M | 19.13% |
| 2024-12-31 | $569.90M | $2.89B | $1.89B | $69.10M | $338.50M | 19.70% |
| 2024-09-30 | $571.20M | $2.88B | $1.87B | $69.00M | $343.20M | 19.86% |
| 2024-06-30 | $587.20M | $2.88B | $1.85B | $69.90M | $348.70M | 20.41% |
| 2024-03-31 | $643.50M | $2.93B | $1.84B | $68.90M | $354.10M | 21.97% |
| 2023-12-31 | $676.00M | $2.95B | $1.82B | $68.40M | $353.40M | 22.92% |
| 2023-09-30 | $644.80M | $2.93B | $1.81B | $65.90M | $349.10M | 22.03% |
| 2023-06-30 | $653.70M | $2.87B | $1.77B | $63.10M | $326.40M | 22.81% |
| 2023-03-31 | $699.60M | $2.88B | $1.76B | $61.00M | $319.50M | 24.26% |
| 2022-12-31 | $734.00M | $2.89B | $1.75B | $58.50M | $316.90M | 25.43% |
| 2022-09-30 | $788.30M | $2.91B | $1.73B | $56.30M | $329.20M | 27.10% |
| 2022-06-30 | $783.50M | $2.93B | $1.73B | $55.80M | $354.80M | 26.75% |
| 2022-03-31 | $766.40M | $2.88B | $1.69B | $55.20M | $366.00M | 26.60% |
| 2021-12-31 | $752.30M | $2.83B | $1.66B | $52.80M | $362.80M | 26.57% |
| 2021-09-30 | $684.40M | $2.68B | $1.59B | $52.00M | $341.10M | 25.53% |
| 2021-06-30 | $602.20M | $2.52B | $1.53B | $51.40M | $325.40M | 23.87% |
| 2021-03-31 | $494.50M | $2.33B | $1.45B | $48.40M | $310.40M | 21.26% |
| 2020-12-31 | $406.90M | $2.15B | $1.38B | $46.90M | $302.00M | 18.95% |
| 2020-09-30 | $368.90M | $2.04B | $1.33B | $44.20M | $294.70M | 18.11% |
| 2020-06-30 | $337.00M | $1.95B | $1.28B | $41.00M | $283.30M | 17.32% |
| 2020-03-31 | $313.90M | $1.89B | $1.26B | $39.80M | $275.90M | 16.63% |
| 2019-12-31 | $296.60M | $1.84B | $1.23B | $38.90M | $272.70M | 16.12% |
| 2019-09-30 | $284.30M | $1.79B | $1.21B | $38.50M | $263.40M | 15.87% |
| 2019-06-30 | $277.80M | $1.77B | $1.19B | $39.30M | $263.50M | 15.72% |
| 2019-03-31 | $257.60M | $1.75B | $1.19B | $40.50M | $263.20M | 14.76% |
| 2018-12-31 | $240.30M | $1.72B | $1.17B | $40.30M | $262.90M | 13.99% |
| 2018-09-30 | $238.00M | $1.71B | $1.17B | $40.20M | $259.40M | 13.91% |
| 2018-06-30 | $240.10M | $1.68B | $1.15B | $39.20M | $257.10M | 14.32% |
| 2018-03-31 | $221.80M | $1.63B | $1.11B | $38.40M | $248.40M | 13.63% |
| 2017-12-31 | $228.90M | $1.60B | $1.09B | $39.10M | $242.60M | 14.31% |
| 2017-09-30 | $222.20M | $1.57B | $1.06B | $39.00M | $244.60M | 14.19% |
| 2017-06-30 | $209.60M | $1.54B | $1.04B | $38.90M | $241.40M | 13.57% |
| 2017-03-31 | $228.10M | $1.53B | $1.02B | $37.70M | $243.30M | 14.86% |
| 2016-12-31 | $196.80M | $1.51B | $1.01B | $36.80M | $239.80M | 13.04% |
| 2016-09-30 | $187.70M | $1.49B | $989.20M | $37.20M | $241.30M | 12.63% |
| 2016-06-30 | $132.90M | $1.45B | $969.80M | $36.70M | $237.60M | 9.14% |
| 2016-03-31 | $110.80M | $1.43B | $956.60M | $36.00M | $235.90M | 7.77% |
| 2015-12-31 | $128.60M | $1.40B | $944.00M | $34.10M | $233.00M | 9.19% |
| 2015-09-30 | $128.00M | $1.39B | $944.00M | $31.90M | $229.40M | 9.21% |
| 2015-06-30 | $175.50M | $1.40B | $953.80M | $33.00M | $230.80M | 12.52% |
| 2015-03-31 | $190.50M | $1.41B | $959.40M | $34.80M | $227.50M | 13.51% |
| 2014-12-31 | $182.00M | $1.42B | $973.60M | $37.30M | $228.70M | 12.80% |
| 2014-09-30 | $174.30M | $1.41B | $969.60M | $39.20M | $229.90M | 12.32% |
| 2014-06-30 | $169.90M | $1.40B | $959.90M | $39.20M | $230.10M | 12.13% |
| 2014-03-31 | $158.40M | $1.38B | $946.40M | $38.80M | $232.20M | 11.51% |
| 2013-12-31 | $162.40M | $1.37B | $933.70M | $37.90M | $234.90M | 11.87% |
| 2013-09-30 | $157.00M | $1.35B | $921.60M | $36.80M | $233.50M | 11.65% |
| 2013-06-30 | $143.70M | $1.31B | $898.70M | $35.30M | $231.10M | 10.98% |
| 2013-03-31 | $136.70M | $1.29B | $891.20M | $34.00M | $225.90M | 10.60% |
| 2012-12-31 | $135.10M | $1.27B | $878.70M | $33.20M | $218.10M | 10.67% |
| 2012-09-30 | $130.60M | $1.24B | $864.80M | $31.80M | $207.90M | 10.53% |
| 2012-06-30 | $130.40M | $1.23B | $863.60M | $31.40M | $199.70M | 10.60% |
| 2012-03-31 | $122.50M | $1.21B | $860.80M | $30.50M | $191.80M | 10.10% |
| 2011-12-31 | $109.60M | $1.19B | $853.00M | $29.10M | $191.10M | 9.19% |
| 2011-09-30 | $88.50M | $1.17B | $841.70M | $28.80M | $195.30M | 7.54% |
| 2011-06-30 | $87.80M | $1.15B | $826.20M | $27.00M | $194.50M | 7.62% |
| 2011-03-31 | $90.60M | $1.13B | $801.50M | $25.40M | $191.70M | 8.05% |
| 2010-12-31 | $90.70M | $1.10B | $786.60M | $23.90M | $187.70M | 8.21% |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $97.50M | $1.06B | $752.10M | $19.90M | $177.70M | 9.24% |
| 2009-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | $124.10M | $1.05B | $748.50M | $18.70M | $159.30M | 11.81% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |